Search Within

Gastrointestinal Oncology Service

  1. "British Journal of Cancer"
Formats
  1. Journal Article (15)
  2. Meeting Abstract (1)
Groups
  1. Department of Medicine (16)
  2. Solid Tumor Oncology Division (16)
  3. Center for Pancreatic Cancer Research (8)
  4. Biostatistics Service (4)
  5. Department of Pathology and Laboratory Medicine (4)
  6. Epidemiology and Biostatistics (4)

More Groups

People
  1. David Kelsen (4)
  2. Leonard Saltz (4)
  3. David Ilson (3)
  4. Eileen O'Reilly (3)
  5. Diane Reidy (2)
  6. Ghassan Abou-Alfa (2)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (2)
  4. 2020 (1)
  5. 2019 (1)
  6. 2018 (1)

More Years

Publications
  1. British Journal of Cancer (16)
Publishers
  1. Nature Publishing Group (16)

Results (16)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • COLUMBIA-1: A randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancer
    Journal Article

    Segal, N. H.; Tie, J.; Kopetz, S.; Ducreux, M.; Chen, E.; Dienstmann, R.; Hollebecque, A.; Reilley, M. J.; Elez, E.; Cosaert, J.; more...
    British Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas
    Journal Article

    Raj, N.; Chan, J. A.; Wang, S. J.; Aggarwal, R. R.; Calabrese, S.; DeMore, A.; Fong, L.; Grabowsky, J.; Hope, T. A.; Kolli, K. P.; more...
    British Journal of Cancer (2023)

    Fulltext@MSK | Save
  • Sleep and cancer recurrence and survival in patients with resected Stage III colon cancer: Findings from CALGB/SWOG 80702 (Alliance)
    Journal Article

    Lee, S.; Ma, C.; Shi, Q.; Meyers, J.; Kumar, P.; Couture, F.; Kuebler, P.; Krishnamurthi, S.; Lewis, D.; Tan, B.; more...
    British Journal of Cancer (2023)

    Fulltext@MSK | Save
  • Immune biomarkers and response to checkpoint inhibition of BRAF(V600) and BRAF non-V600 altered lung cancers
    Journal Article

    Murciano-Goroff, Y. R.; Pak, T.; Mondaca, S.; Flynn, J. R.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Plodkowski, A. J.; Wu, S. L.; Kris, M. G.; more...
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade
    Journal Article

    Kelley, R. K.; Miksad, R.; Cicin, I.; Chen, Y. H.; Klümpen, H. J.; Kim, S.; Lin, Z. Z.; Youkstetter, J.; Hazra, S.; Sen, S.; more...
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancer
    Journal Article

    Park, W.; Mezquita, L.; Okabe, N.; Chae, Y. K.; Kwon, D.; Saravia, D.; Auclin, E.; Planchard, D.; Caramella, C.; Ferrara, R.; more...
    British Journal of Cancer (2020)

    Fulltext@MSK | Save
  • BEACON: A randomised, phase 3 study of encorafenib and cetuximab +/- binimetinib vs. choice of either irinotecan or FOLFIRI plus cetuximab in BRAF V600E-mutant metastatic colorectal cancer patients
    Meeting Abstract

    Wasan, H.; Arkenau, T.; Braun, M.; Samuel, L.; Graham, J.; Kopetz, S.; Grothey, A.; Van Cutsem, E.; Yaeger, R.; Yoshino, T.; more...
    British Journal of Cancer (2019)

    Fulltext@MSK | Save
  • Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancer
    Journal Article

    Loupakis, F.; Hurwitz, H. I.; Saltz, L.; Arnold, D.; Grothey, A.; Nguyen, Q. L.; Osborne, S.; Talbot, J.; Srock, S.; Lenz, H. J.
    British Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer
    Journal Article

    Golan, T.; Sella, T.; O'Reilly, E. M.; Katz, M. H. G.; Epelbaum, R.; Kelsen, D. P.; Borgida, A.; Maynard, H.; Kindler, H.; Friedmen, E.; more...
    British Journal of Cancer (2017)

    Fulltext@MSK | Save
  • Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma
    Journal Article

    Chhabra, A.; Ong, L. T.; Kuk, D.; Ku, G.; Ilson, D.; Janjigian, Y. Y.; Wu, A.; Schoder, H.; Goodman, K. A.
    British Journal of Cancer (2015)

    Fulltext@MSK | Save